A Clinical Trial to Assess the Safety, Tolerability and Immunogenicity of MenABCWY in Healthy Infants

Clinical trial NCT04645966 · TERMINATED

Trial details

NCT number: NCT04645966
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Meningococcal Vaccine

Start date: 2020-11-26
Primary completion: 2022-09-15
Enrollment: 326

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.